Literature DB >> 28825597

Epigenetics at the base of alternative splicing changes that promote colorectal cancer.

Alberto R Kornblihtt.   

Abstract

Chromatin modification influences gene expression by either repressing or activating genes, depending on the specific histone mark. Chromatin structure can also influence alternative splicing of transcripts; however, the mechanisms by which epigenetic marks influence splicing are poorly understood. A report in the current issue of the JCI highlights the biological importance of the coordinated control of alternative pre-mRNA splicing by chromatin structure and transcriptional elongation. Yuan et al. found that mutation of the histone methyl transferase SEDT2 affects alternative splicing fates of several key regulatory genes, including those involved in Wnt signaling. As a consequence, loss of SEDT2 in the intestine aggravated Wnt/β-catenin signaling effects, thereby leading to colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28825597      PMCID: PMC5669579          DOI: 10.1172/JCI96497

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  A slow RNA polymerase II affects alternative splicing in vivo.

Authors:  Manuel de la Mata; Claudio R Alonso; Sebastián Kadener; Juan P Fededa; Matías Blaustein; Federico Pelisch; Paula Cramer; David Bentley; Alberto R Kornblihtt
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

2.  Deciphering the splicing code.

Authors:  Yoseph Barash; John A Calarco; Weijun Gao; Qun Pan; Xinchen Wang; Ofer Shai; Benjamin J Blencowe; Brendan J Frey
Journal:  Nature       Date:  2010-05-06       Impact factor: 49.962

3.  Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing.

Authors:  Robert J Sims; Scott Millhouse; Chi-Fu Chen; Brian A Lewis; Hediye Erdjument-Bromage; Paul Tempst; James L Manley; Danny Reinberg
Journal:  Mol Cell       Date:  2007-11-30       Impact factor: 17.970

4.  Chromatin organization marks exon-intron structure.

Authors:  Schraga Schwartz; Eran Meshorer; Gil Ast
Journal:  Nat Struct Mol Biol       Date:  2009-09       Impact factor: 15.369

Review 5.  Regulation of alternative splicing through coupling with transcription and chromatin structure.

Authors:  Shiran Naftelberg; Ignacio E Schor; Gil Ast; Alberto R Kornblihtt
Journal:  Annu Rev Biochem       Date:  2015       Impact factor: 23.643

Review 6.  Epigenetics in alternative pre-mRNA splicing.

Authors:  Reini F Luco; Mariano Allo; Ignacio E Schor; Alberto R Kornblihtt; Tom Misteli
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

7.  Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation.

Authors:  Ignacio E Schor; Ana Fiszbein; Ezequiel Petrillo; Alberto R Kornblihtt
Journal:  EMBO J       Date:  2013-07-26       Impact factor: 11.598

8.  Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing.

Authors:  Ignacio E Schor; Nicolás Rascovan; Federico Pelisch; Mariano Alló; Alberto R Kornblihtt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-26       Impact factor: 11.205

9.  Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs.

Authors:  Hagen Tilgner; David G Knowles; Rory Johnson; Carrie A Davis; Sudipto Chakrabortty; Sarah Djebali; João Curado; Michael Snyder; Thomas R Gingeras; Roderic Guigó
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

10.  Pre-mRNA splicing is facilitated by an optimal RNA polymerase II elongation rate.

Authors:  Nova Fong; Hyunmin Kim; Yu Zhou; Xiong Ji; Jinsong Qiu; Tassa Saldi; Katrina Diener; Ken Jones; Xiang-Dong Fu; David L Bentley
Journal:  Genes Dev       Date:  2014-12-01       Impact factor: 11.361

View more
  9 in total

1.  The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer.

Authors:  Amit Gupta; Sandhya Yadav; Archana Pt; Jharna Mishra; Atul Samaiya; Rajendra Kumar Panday; Sanjeev Shukla
Journal:  Lab Invest       Date:  2020-07-15       Impact factor: 5.662

2.  Crosstalk between macrophage-derived PGE2 and tumor UHRF1 drives hepatocellular carcinoma progression.

Authors:  Jian Zhang; Hongyan Zhang; Xiuli Ding; Jia Hu; Yongkui Li; Jinxiang Zhang; Hui Wang; Shanshan Qi; Aqing Xie; Jie Shi; Mengxi Xiang; Yawen Bin; Guobin Wang; Lin Wang; Zheng Wang
Journal:  Theranostics       Date:  2022-05-01       Impact factor: 11.600

3.  Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer.

Authors:  Wen-Juan Ma; Xing Wang; Wen-Ting Yan; Zhong-Guo Zhou; Zhi-Zhong Pan; Gong Chen; Rong-Xin Zhang
Journal:  World J Gastroenterol       Date:  2018-05-28       Impact factor: 5.742

4.  Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events.

Authors:  Hua-Yu Wu; Yi Wei; Li-Min Liu; Zhong-Biao Chen; Qi-Ping Hu; Shang-Ling Pan
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

Review 5.  Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer.

Authors:  Koji Kitamura; Keisuke Nimura
Journal:  Cells       Date:  2021-04-16       Impact factor: 6.600

Review 6.  Alternative Splicing in Cancer and Immune Cells.

Authors:  Antoine Bernard; Romain Boidot; Frédérique Végran
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

Review 7.  Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI.

Authors:  Simona-Ruxandra Volovat; Iolanda Augustin; Daniela Zob; Diana Boboc; Florin Amurariti; Constantin Volovat; Cipriana Stefanescu; Cati Raluca Stolniceanu; Manuela Ciocoiu; Eduard Alexandru Dumitras; Mihai Danciu; Delia Gabriela Ciobanu Apostol; Vasile Drug; Sinziana Al Shurbaji; Lucia-Georgiana Coca; Florin Leon; Adrian Iftene; Paul-Corneliu Herghelegiu
Journal:  Cancers (Basel)       Date:  2022-10-03       Impact factor: 6.575

8.  Prognostic alternative splicing signature in cervical squamous cell carcinoma.

Authors:  Hua-Yu Wu; Qi-Qi Li; Liang Liang; Lan-Lan Qiu; Hong-Wei Wei; Bing-Ying Huang; Chen Gang-; Rong-Quan He; Zhi-Guang Huang; Wei Hou; Qi-Ping Hu; Shang-Ling Pan
Journal:  IET Syst Biol       Date:  2020-12       Impact factor: 1.615

Review 9.  Histone Modifications and their Role in Colorectal Cancer (Review).

Authors:  Jingchun Qin; Bin Wen; Yuqi Liang; Weitao Yu; Huixuan Li
Journal:  Pathol Oncol Res       Date:  2019-05-04       Impact factor: 3.201

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.